BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10331697)

  • 1. A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease.
    Varho T; Komu M; Sonninen P; Holopainen I; Nyman S; Manner T; Sillanpää M; Aula P; Lundbom N
    Neurology; 1999 May; 52(8):1668-72. PubMed ID: 10331697
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Laccetta G; De Nardo MC; Cellitti R; Angeloni U; Terrin G
    Neuroradiol J; 2022 Dec; 35(6):667-677. PubMed ID: 35698266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of magnetic resonance spectroscopy in diagnosis of neurodegenerative diseases: A systematic review.
    Abbaspour F; Mohammadi N; Amiri H; Cheraghi S; Ahadi R; Hormozi-Moghaddam Z
    Heliyon; 2024 May; 10(9):e30521. PubMed ID: 38726104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol in human brain by magnetic resonance spectroscopy: correlation with blood and breath levels, relaxation, and magnetization transfer.
    Fein G; Meyerhoff DJ
    Alcohol Clin Exp Res; 2000 Aug; 24(8):1227-35. PubMed ID: 10968662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation.
    Moffett JR; Arun P; Ariyannur PS; Namboodiri AM
    Front Neuroenergetics; 2013 Dec; 5():11. PubMed ID: 24421768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of l-Tryptophan by down-field
    Nanga RPR; Elliott MA; Swain A; Wilson N; Swago S; Soni ND; Witschey WR; Reddy R
    Magn Reson Med; 2022 Dec; 88(6):2371-2377. PubMed ID: 36005819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Characterization of the Clinical Course of Intermediate-Severe Salla Disease.
    Chapleau A; Mirchi A; Tran LT; Poulin C; Bernard G
    Pediatr Neurol; 2023 Nov; 148():133-137. PubMed ID: 37713976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The full spectrum of MRI findings in 18 patients with Canavan disease: new insights into the areas of selective susceptibility.
    Rahimian E; D'Arco F; Sudhakar S; Tahsini MR; Azin N; Morovvati M; Karimzadeh P; Farahvash MA
    Neuroradiology; 2024 Jun; ():. PubMed ID: 38880823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy.
    Tsuji M; Aida N; Obata T; Tomiyasu M; Furuya N; Kurosawa K; Errami A; Gibson KM; Salomons GS; Jakobs C; Osaka H
    J Inherit Metab Dis; 2010 Feb; 33(1):85-90. PubMed ID: 20052547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases.
    Ostojic J; Kozic D; Panjkovic M; Georgievski-Brkic B; Dragicevic D; Lovrenski A; Boban J
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674308
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychiatric symptoms in Salla disease.
    Aulanko I; Rahikkala E; Moilanen J
    Eur Child Adolesc Psychiatry; 2023 Oct; 32(10):2043-2047. PubMed ID: 35796883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical
    Whitehead MT; Lai LM; Blüml S
    Neuroradiology; 2022 Jun; 64(6):1111-1126. PubMed ID: 35224679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo Human MR Spectroscopy Using a Clinical Scanner: Development, Applications, and Future Prospects.
    Tomiyasu M; Harada M
    Magn Reson Med Sci; 2022 Mar; 21(1):235-252. PubMed ID: 35173095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR spectroscopy in pediatric neuroradiology.
    Liserre R; Pinelli L; Gasparotti R
    Transl Pediatr; 2021 Apr; 10(4):1169-1200. PubMed ID: 34012861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 13-year follow-up of Finnish patients with Salla disease.
    Paavola LE; Remes AM; Harila MJ; Varho TT; Korhonen TT; Majamaa K
    J Neurodev Disord; 2015; 7(1):20. PubMed ID: 26171070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Unusual Developmental Profile of Salla Disease in a Patient with the SallaFIN Mutation.
    Paavola LE; Remes AM; Sonninen PH; Kiviniemi VV; Korhonen TT; Majamaa K
    Case Rep Neurol Med; 2012; 2012():615721. PubMed ID: 23227378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel proton MR spectroscopy findings in adenylosuccinate lyase deficiency.
    Zulfiqar M; Lin DD; Van der Graaf M; Barker PB; Fahrner JA; Marie S; Morava E; De Boer L; Willemsen MA; Vining E; Horská A; Engelke U; Wevers RA; Maegawa GH
    J Magn Reson Imaging; 2013 Apr; 37(4):974-80. PubMed ID: 23055421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.
    van der Graaf M
    Eur Biophys J; 2010 Mar; 39(4):527-40. PubMed ID: 19680645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder.
    Rossi A; Biancheri R; Zara F; Bruno C; Uziel G; van der Knaap MS; Minetti C; Tortori-Donati P
    AJNR Am J Neuroradiol; 2008 Feb; 29(2):301-5. PubMed ID: 17974614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.
    Moffett JR; Ross B; Arun P; Madhavarao CN; Namboodiri AM
    Prog Neurobiol; 2007 Feb; 81(2):89-131. PubMed ID: 17275978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.